China NT Pharma Group Company Limited (HKG:1011)
Hong Kong
· Delayed Price · Currency is HKD
0.670
+0.020 (3.08%)
Apr 29, 2026, 3:38 PM HKT
HKG:1011 Ratios and Metrics
Market cap in millions HKD. Fiscal year is January - December.
Millions HKD. Fiscal year is Jan - Dec.
| Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Apr '26 Apr 28, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Market Capitalization | 636 | 553 | 71 | 145 | 171 | 135 | |
| Market Cap Growth | 292.93% | 675.38% | -50.91% | -15.27% | 26.76% | -40.83% | |
| Enterprise Value | 980 | 895 | 445 | 993 | 1,082 | 992 | |
| Last Close Price | 0.67 | 0.82 | 0.27 | 0.55 | 0.90 | 0.71 | |
| Forward PE | - | 15.33 | 15.33 | 15.33 | 15.33 | 15.33 | |
| PS Ratio | 23.65 | 20.57 | 1.77 | 17.90 | - | 0.49 | |
| PB Ratio | -2.09 | -1.81 | -0.17 | -0.39 | -0.63 | -0.52 | |
| P/FCF Ratio | - | - | - | 3.32 | 4.78 | - | |
| P/OCF Ratio | - | - | - | 2.61 | 4.19 | - | |
| EV/Sales Ratio | 36.45 | 33.29 | 11.01 | 122.42 | - | 3.57 | |
| EV/FCF Ratio | - | - | - | 22.69 | 30.19 | - | |
| Debt / Equity Ratio | -1.16 | -1.16 | -0.94 | -1.02 | -3.42 | -3.94 | |
| Debt / FCF Ratio | - | - | - | 8.68 | 26.06 | - | |
| Net Debt / Equity Ratio | -1.13 | -1.13 | -0.92 | -1.01 | -3.39 | -3.89 | |
| Net Debt / EBITDA Ratio | -25.13 | -25.13 | -27.80 | -6.65 | -87.43 | -14.36 | |
| Net Debt / FCF Ratio | - | - | -39.63 | 8.64 | 25.87 | -6.05 | |
| Asset Turnover | 0.07 | 0.07 | 0.11 | 0.01 | - | 0.20 | |
| Inventory Turnover | 51.14 | 51.14 | - | - | - | 2.74 | |
| Quick Ratio | 0.02 | 0.02 | 0.01 | 0.02 | 0.05 | 0.05 | |
| Current Ratio | 0.03 | 0.03 | 0.02 | 0.02 | 0.06 | 0.30 | |
| Return on Assets (ROA) | -2.27% | -2.27% | -2.49% | -5.26% | -1.69% | -5.19% | |
| Return on Invested Capital (ROIC) | -34.69% | -862.50% | - | -19.29% | -4.46% | -12.65% | |
| Return on Capital Employed (ROCE) | 4.50% | 4.50% | 3.40% | 16.70% | 16.20% | -157.40% | |
| Earnings Yield | -4.56% | -5.24% | -79.63% | -108.91% | -43.79% | -135.74% | |
| FCF Yield | - | - | -13.80% | 30.14% | 20.92% | -123.43% | |
| Buyback Yield / Dilution | -133.61% | -133.61% | -10.72% | -25.59% | -0.51% | -0.14% | |
| Total Shareholder Return | -133.61% | -133.61% | -10.72% | -25.59% | -0.51% | -0.14% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.